These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives. Cascioferro S, Parrino B, Spanò V, Carbone A, Montalbano A, Barraja P, Diana P, Cirrincione G. Eur J Med Chem; 2017 Dec 15; 142():74-86. PubMed ID: 28615111 [Abstract] [Full Text] [Related]
6. 1,3,5-Triazines: A promising scaffold for anticancer drugs development. Cascioferro S, Parrino B, Spanò V, Carbone A, Montalbano A, Barraja P, Diana P, Cirrincione G. Eur J Med Chem; 2017 Dec 15; 142():523-549. PubMed ID: 29046238 [Abstract] [Full Text] [Related]
7. Therapeutic advancement of benzothiazole derivatives in the last decennial period. Tariq S, Kamboj P, Amir M. Arch Pharm (Weinheim); 2019 Jan 15; 352(1):e1800170. PubMed ID: 30488989 [Abstract] [Full Text] [Related]
11. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds. Abdellatif KRA, Bakr RB. Bioorg Chem; 2018 Aug 01; 78():341-357. PubMed ID: 29627655 [Abstract] [Full Text] [Related]
12. Privileged s-triazines: structure and pharmacological applications. Shah DR, Modh RP, Chikhalia KH. Future Med Chem; 2014 Mar 01; 6(4):463-77. PubMed ID: 24635525 [Abstract] [Full Text] [Related]
13. 1,3,5-Triazine: A versatile pharmacophore with diverse biological activities. Singh S, Mandal MK, Masih A, Saha A, Ghosh SK, Bhat HR, Singh UP. Arch Pharm (Weinheim); 2021 Jun 01; 354(6):e2000363. PubMed ID: 33760298 [Abstract] [Full Text] [Related]
15. Bioactive Benzofuran derivatives: A review. Khanam H, Shamsuzzaman. Eur J Med Chem; 2015 Jun 05; 97():483-504. PubMed ID: 25482554 [Abstract] [Full Text] [Related]
16. The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications. Kushwaha N, Sharma CS. Mini Rev Med Chem; 2020 Jun 05; 20(20):2104-2122. PubMed ID: 32727324 [Abstract] [Full Text] [Related]
17. 1,2,4-triazine analogs as novel class of therapeutic agents. Kumar R, Sirohi TS, Singh H, Yadav R, Roy RK, Chaudhary A, Pandeya SN. Mini Rev Med Chem; 2014 Feb 05; 14(2):168-207. PubMed ID: 24479860 [Abstract] [Full Text] [Related]
18. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity. Guo H, Diao QP. Curr Top Med Chem; 2020 Feb 05; 20(16):1481-1492. PubMed ID: 32156236 [Abstract] [Full Text] [Related]
19. Synthesis of some new heterobicyclic compounds containing spiro-1,2,4-triazine moiety as potential anti HIV and anticancer agents. Abdel-Rahman RM, Seada M, Fawzy M, el-Baz I. Boll Chim Farm; 1994 Jun 05; 133(6):374-80. PubMed ID: 7917184 [Abstract] [Full Text] [Related]
20. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos. Farooq M, Sharma A, Almarhoon Z, Al-Dhfyan A, El-Faham A, Taha NA, Wadaan MAM, Torre BG, Albericio F. Bioorg Chem; 2019 Jun 05; 87():457-464. PubMed ID: 30927586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]